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Abstract: The results of several experimental studies have shown that ascorbic 
acid inhibits tumor growth and metastasis. Ascorbic acid is an antioxidant that 
acts as a scavenger for a wide range of reactive oxygen species (ROS). Both 
tumour metastasis and cell migration have been correlated with the intracellular 
ROS level, so it was postulated that the inhibitory effect of ascorbic acid 
derivatives on cell motility may be caused by scavenging of ROS. Time-lapse 
analyses of Walker 256 carcinosarcoma cell migration showed that both the 
speed of movement and the cell displacement were inhibited by ascorbic acid 
applied in concentrations ranging from 10 to 250 μM. This effect correlated with 
a reduction in the intracellular ROS level in WC 256 cells, suggesting that ROS 
scavenging may be a mechanism responsible for the inhibition of WC 256 cell 
migration. However, another potent antioxidant, N-acetyl-L-cysteine, also 
efficiently decreased the intracellular ROS level in WC 256 cells, but did not 
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affect the migration of the investigated cells. These results demonstrate that 
intact, unmodified ascorbic acid applied in physiologically relevant and non-
toxic concentrations exerts an inhibitory effect on the migration of WC 256 
carcinosarcoma cells, and that this may be one of the factors responsible for the 
anti-metastatic activity of vitamin C. However, our data does not support the 
hypothesis that the scavenging of intracellular ROS is the main mechanism in 
the inhibition of cancer cell migration by ascorbic acid. 
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INTRODUCTION 
 
The effect of ascorbic acid on tumour development remains a controversial 
subject [1, 2]. However, the tumour growth-inhibiting effect of ascorbic acid has 
been demonstrated in several epidemiological and experimental studies [1, 3, 4]. 
While many reports have shown the cytotoxic effects of ascorbic acid on  
a number of malignant and non-malignant cell lines in vitro and in vivo, much 
less is known about its inhibitory effect on the formation of metastases by cancer 
cells [4-8]. Metastasis is a complex multistep process, and is a major cause of 
death amongst cancer patients. The induction of cancer cell migration is a key 
step in tumour metastasis, and a correlation between the motility of tumour cells 
and their metastatic potential has been demonstrated in several studies [9, 10].  
Ascorbic acid (vitamin C) is a major water-soluble antioxidant that acts as  
a scavenger for a wide range of reactive oxygen species (ROS). As an electron 
donor, and therefore a reducing agent, it prevents other compounds from being 
oxidized [11]. Ascorbic acid is, among other effects, capable of regenerating 
vitamin E from the tocopheroxyl radical, which is formed as a result of the 
inhibition of lipid peroxidation by vitamin E [12]. It was also shown that 
ascorbic acid protects against DNA damage induced by hydrogen peroxide in 
human lymphocytes [13]. Moreover, it was demonstrated that the levels of 
hydroxyl radicals in cells treated with ascorbic acid derivatives were markedly 
diminished relative to those of non-treated cells as evaluated by the electron spin 
resonance method using the spin trapping agent DMPO [14]. The attenuation of 
intracellular reactive oxygen species by derivatives of vitamin C was also shown 
with the redox indicator CDCFH-DA [6]. However, although the antioxidant 
activities of vitamin C have been shown in several in vitro experiments, in vivo 
vitamin C treatment has not resulted in changes in the biomarkers of oxidation or 
in the clinical outcome [11]. In addition, ascorbic acid can exert a pro-oxidant 
activity under certain conditions, particularly in the presence of transition metal 
ions or alkalis [15]. Since both tumour metastasis and cell migration have been 
correlated with the intracellular levels of ROS, it was postulated that the 
inhibitory effect of ascorbic acid on cell motility may be caused by scavenging 
of ROS [6, 8, 16, 17]. However, it was demonstrated that the inhibitory effects 
were characteristic for ascorbic acid derivatives rather than for intact, 
unmodified ascorbic acid [6, 8]. 
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The specific aim of this study was to establish if intact ascorbic acid inhibits the 
migration of invasive Walker 256 carcinosarcoma cells. We also attempted to 
verify the hypothesis that the inhibition of cancer cell migration by ascorbic acid 
is caused by scavenging of the intracellular reactive oxygen species. 
 
MATERIAL AND METHODS 
 
Cell culture 
Walker 256 carcinosarcoma cells were cultured in RPMI-1640 medium (Sigma, 
St. Louis, MO/USA), supplemented with 5% heat-inactivated fetal calf serum 
(FCS; Gibco Lab., New York, USA), 100 I.U./ml penicilin, 10 μg/ml neomycin 
and 100 μg/ml streptomycin (Polfa, Tarchomin, Poland) in a humidified 
atmosphere with 5% CO2 at 37ºC [18]. 
 
Time lapse-monitoring of cell movement 
Time-lapse monitoring of cell movement was carried out as described previously 
[19, 20]. WC 256 cells were plated to a Corning flask at a density of  
20,000 cells/cm2, and incubated in the culture medium in a humidified 
atmosphere with 5% CO2 at 37ºC for 24 hours. Subsequently, the culture 
medium was replaced and the cells were incubated for one hour in the presence 
of various concentrations of L-ascorbic acid (10-250 μM) or N-acetyl-L-cysteine  
(0.5-10 mM) (Sigma, St. Louis, MO/USA). Then, cell movement was recorded 
for 2 hours with a Hitachi CCD camera attached to an Olympus IMT-2 inverted 
microscope. In these experiments, we did not observe any significant decrease in 
the medium pH in the presence of 10-250 μM ascorbic acid. The tracks of 
individual Walker 256 carcinosarcoma cells were generated as described 
previously [19, 20]. Trajectories were constructed from 48 subsequent cell 
centroid positions recorded over 2 hours at time intervals of 2.5 minutes, and 
plotted in circular diagrams. Parameters characterizing cell locomotion were 
computed for each cell population as described previously [19, 20]. A total of  
50 cells were analyzed for each value measured.  
 
Cell viability 
To determine the effect of ascorbic acid and N-acetyl-L-cysteine (NAC) on cell 
viability, WC 256 cells were plated to 6-well plates at a density of  
10,000 cells/cm2 and cultured for 24 hours. Then the cells were incubated for  
3 hours with different concentrations of ascorbic acid or NAC. Thereafter, the 
cells were harvested with trypsin treatment, and the number of viable cells was 
determined by the fluoresceine diacetate and ethidium bromide test [21]. 
 
Measurement of reactive oxygen species 
To measure the generation of ROS, WC 256 cells were incubated for 1 hour in 
the presence of different concentrations of ascorbic acid or NAC. Then the cells 
were loaded for 15 minutes with 2’,7’-dichlorofluorescein diacetate (DCF-DA; 
Sigma, St. Louis, MO/USA) at a final concentration of 10 μg/ml in PBS 
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supplemented with 5.6 mM glucose and 1% FCS. At the end of incubation, the 
monolayer was rinsed with PBS and the cells were examined alive at 37ºC under 
a Leica DM IRE2 fluorescence microscope equipped with a Leica DC350 FX 
digital camera and a fluorescein filter set. The integrated fluorescence intensity 
of at least 50 cells for each specific experimental treatment was measured with  
a Leica FW4000 image analysis system. 
 
Statistical analysis 
Each parameter was calculated as the mean and standard error of the mean 
(SEM). The statistical significance was determined by the t-Student test with  
p < 0.05 considered to indicate significant differences. 
 
RESULTS AND DISCUSSION 
 
Time-lapse analyses of cell migration were carried out in order to investigate the 
effect of ascorbic acid on the motility of WC 256 cells. Representative 
trajectories of cells moving under control conditions and in the presence of 
ascorbic acid are illustrated in circular diagrams in Fig. 1A. Analysis of the 
individual trajectories showed that both the speed of cell movement and cell 
displacement were inhibited by ascorbic acid in a dose-dependent manner (Fig. 1B). 
A statistically significant inhibition of migration was induced by 100 µM 
ascorbic acid. Interestingly, we did not observe any apparent effect of ascorbic 
acid on the morphology and polarization of WC 256 cells (data not shown). 
This inhibitory effect was independent of cytotoxic activity, as ascorbic acid did 
not affect the viability of WC 256 in concentrations ranging from 10 to 250 μM 
(Fig. 2). We demonstrated that ascorbic acid may significantly inhibit the 
migration of invasive cancer cells at a physiologically relevant concentration 
which may be attained by oral administration. Ascorbic acid administered orally 
at a dose of 1.25 g produced mean peak plasma concentrations of 135 ± 20.6 
μmol/l and 885 ± 201.2 μmol/l for intravenous administration [22]. Our results 
suggest that the anti-metastatic effect of ascorbic acid [5-8] may at least in part 
be due to inhibition of the migration of cancer cells. Similar results were 
obtained by Nagao et al. [6]; however, they observed significant inhibition of 
melanoma B16BL6 random movement by ascorbic acid-2-O-phosphate but not 
by intact ascorbic acid. The suppression of human lung carcinoma migration by 
ascorbic acid-2-O-phosphate-6-O-laureate was also observed by Liu et al. [8]. 
Here, we show that not only ascorbic acid derivatives but also intact, unmodified 
ascorbic acid inhibits the motility of cancer cells. 
Increasing evidence indicates that at low levels, ROS can function as signaling 
molecules participating in the regulation of cell proliferation, migration and 
adhesion [17, 23, 24]. It was suggested that a decrease in the intracellular ROS 
level induced by ascorbic acid may be responsible for the inhibition of cell 
motility [6, 8]. To determine whether intracellular ROS levels correlate with the 
inhibition of WC 256 cell migration, we subsequently measured DCF-DA 
fluorescence in cells treated with various concentrations of ascorbic acid (Fig. 3). 
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Fig. 1. The effect of Asc and NAC on the motility of WC 256 cells. A – Composite 
trajectories of migrating cells are displayed in circular diagrams drawn with the initial 
point of each trajectory placed at the origin of the plot. Each trajectory was constructed 
from 48 successive positions of the cell centroid recorded at 2.5-minute intervals. Scale 
bars: [μm]. B and C – Summary of the quantitive data showing the effect of Asc (B) and 
NAC (C) on the locomotion of WC 256 cells. For each value measured, 50 cells were 
analyzed. The values are the means from 3-4 independent experiments. The parameters 
translocation and speed of cell movement were presented as a percentage of the values for 
the control. Error bars represent SEM,* indicates statistically significant differences.  
 
Fig. 2. The effect of Asc and NAC on the viability of WC 256 cells. The proportion of 
viable cells after 3 hours of incubation with Asc and NAC at various concentrations  
(10-250 μM and 0.5-10 mM, respectively) or with RPMI 1640 (as the control) was 
calculated on the basis of the fluorescein diacetate and ethidium bromide test. The data 
represents the average of three independent experiments, each performed in triplicate. 
Error bars represent SEM. 
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Fig. 3. Asc and NAC reduce the level of ROS in WC 256 cells. WC 256 cells were 
incubated in the presence of different concentrations of ascorbic acid or NAC. Then the 
cells were loaded with DCF-DA. Fluorescence intensity (F.I.) is presented as a percentage 
of the control value. The integrated fluorescence intensity of at least 50 cells was measured 
for each specific experimental treatment. The data represents the average of three 
independent experiments. Error bars represent SEM, * indicates statistically significant 
differences.  
 
Our results demonstrate that ascorbic acid decreases ROS levels in WC 256 cells 
in a dose-dependent manner. This suggests that the scavenging of ROS may be 
responsible for the inhibition of cell migration. To test the hypothesis that  
a decrease in ROS levels in cancer cells leads to the inhibition of their motility, 
we investigated the effect of another potent antioxidant, N-acetyl-L-cysteine, on 
WC 256 cell migration (Fig. 1 A, C) and intracellular ROS levels (Fig. 3). An 
analysis of the cell trajectories showed that the motility of WC 256 cells was not 
affected by NAC in concentrations ranging from 0.5 to 10 mM. However, NAC 
applied at these concentrations efficiently decreased the intracellular ROS levels 
in WC 256 cells. Therefore, our results suggest that, at least in our model,  
a decrease in ROS levels is not sufficient to inhibit cancer cell motility. 
The molecular mechanism of ascorbic acid activity with regard to the inhibition 
of cancer cell migration is not understood, and due to the broad biological 
activity of vitamin C, it is difficult to draw conclusions about the specific 
regulatory pathways involved in the inhibition of cell migration. It was 
suggested that a decrease in the intracellular ROS level induced by ascorbic acid 
derivatives may play an important role in the inhibition of migration, probably 
by interfering with redox-regulated signaling pathways [6, 8, 14]. However, our 
results indicate that the antioxidant effect of ascorbic acid is not by itself 
sufficient to inhibit cell migration. This discrepancy might have resulted from 
the different cell lines used in the experiments. As it was demonstrated that 
different cell types show different sensitivities to ascorbic acid [25], it is possible 
that WC 256 cells are more sensitive to this compound than the cell lines used in 
the previous experiments [6, 8, 14]. Moreover, we also cannot exclude that in 
our model, ascorbic acid derivatives would induce inhibition of WC 256 cell 
migration at a lower concentration than intact vitamin C. However, our data does 
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demonstrate that unmodified ascorbic acid may also be an efficient inhibitor of 
cancer cell migration. The observations of Liu et al. [14] that ascorbic acid 
derivative affects the localization and expression of the small GTP-binding 
protein RhoA suggests that the regulation of this protein by ascorbic acid may be 
involved in the inhibition of cell migration. However, the detailed mechanism of 
this regulation is not known. It was also demonstrated that enrichment of 
intracellular ascorbate content of tumour cells induces, via a post-transcriptional 
inhibition of MMP proenzyme production, a marked decrease in metaloproteinases 
2 and 9, which are involved in the regulation of cell migration [6]. However, further 
experiments elucidating the mechanism of inhibition of cellular movement by 
ascorbic acid are required to get some insight into the underlying signalling and 
regulatory pathways. 
In summary, our results demonstrate that intact, unmodified ascorbic acid in 
physiologically relevant and non-toxic concentrations exerts an inhibitory effect 
on the migration of WC 256 carcinosarcoma cells, and that this may be one of 
the factors responsible for the anti-metastatic activity of vitamin C. It was 
suggested that a decrease in the intracellular ROS level induced by ascorbic acid 
derivatives may play an important role in the inhibition of the migration and 
invasion of cancer cells [6, 8, 14]. However, our data does not support the 
hypothesis that the scavenging of intracellular reactive oxygen species is the 
main mechanism inhibiting cancer cell migration by ascorbic acid, because 
NAC, which also decreased the ROS level in WC 256 cells, did not affect their 
motile activity. 
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